Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis.

about

Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis.

Item

http://www.wikidata.org/entity/Q55267717

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Randomized study of adjunctive ...... generalized myasthenia gravis.

@en

Randomized study of adjunctive ...... generalized myasthenia gravis.

@nl

type

Item

label

Randomized study of adjunctive ...... generalized myasthenia gravis.

@en

Randomized study of adjunctive ...... generalized myasthenia gravis.

@nl

prefLabel

Randomized study of adjunctive ...... generalized myasthenia gravis.

@en

Randomized study of adjunctive ...... generalized myasthenia gravis.

@nl

P1476

Randomized study of adjunctive ...... generalized myasthenia gravis.

@en

P2093

Ashlyn Bassiri

http://www.w3.org/2001/XMLSchema#string

BEL115123 Study Group

http://www.w3.org/2001/XMLSchema#string

Christine L Broderick

http://www.w3.org/2001/XMLSchema#string

Donald B Sanders

http://www.w3.org/2001/XMLSchema#string

Karen Hewett

http://www.w3.org/2001/XMLSchema#string

Marina Zvartau-Hind

http://www.w3.org/2001/XMLSchema#string

Richard A Grove

http://www.w3.org/2001/XMLSchema#string

Todd J Rudo

http://www.w3.org/2001/XMLSchema#string

P2860

Immunosuppressive agents for myasthenia gravis

Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms

International consensus guidance for management of myasthenia gravis: Executive summary

Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

The MG Composite: A valid and reliable outcome measure for myasthenia gravis.

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

P304

e1425-e1434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000005323

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vera Bril

P577

2018-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29661905

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis

P932

5902787

http://www.w3.org/2001/XMLSchema#string